Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan
Background Biosimilars present a significant opportunity for cost savings. However, the uptake of biosimilars has been inconsistent across different regions and drugs, highlighting the need for effective policy interventions. This study aimed to investigate the impact of Japan's reimbursement incent...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2026-12-01
|
| Reeks: | Journal of Pharmaceutical Policy and Practice |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/20523211.2026.2633832 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|